Kathryn Dzintars, Pharm.D., BCPS



  • Lenacapavir is a HIV-1 capsid inhibitor, and is indicated for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection who are failing their current regimen due to resistance, intolerance, and/or safety considerations as part of combination therapy wtih other antivirals.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: September 3, 2023